Operator of a biotechnology company intended to improve outcomes for people with cancer. The company offers a pipeline against validated oncology targets to deliver radioisotopes that emit alpha particles, enabling healthcare providers to improve the cancer patient's survival chances.
Currently, there are no issues on this topic.
